Detalles de la búsqueda
1.
Does integration with national registers improve the data completeness of local COVID-19 contact tracing tools? A register-based study in Norway, May 2020 - September 2021.
BMC Health Serv Res;
24(1): 96, 2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233812
2.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons agedâ¯≥â¯65â¯years: results from a VEBIS network, Europe, October 2021 to July 2023.
Euro Surveill;
29(1)2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179626
3.
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021.
BMC Med;
20(1): 278, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050718
4.
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022.
Euro Surveill;
27(30)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904059
5.
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021.
Euro Surveill;
26(35)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477054
6.
Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020.
Euro Surveill;
26(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33413743
7.
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.
Euro Surveill;
26(47)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823641
8.
Compliance with a boil water advisory after the contamination of a municipal drinking water supply system in Norway.
J Water Health;
18(6): 1084-1090, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328377
9.
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
BMC Infect Dis;
17(1): 541, 2017 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28774261
10.
The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
BMC Infect Dis;
14: 683, 2014 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25495598
11.
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023.
Vaccine;
42(3): 620-628, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38142215
12.
COVID-19 Vaccine Effectiveness Among Adolescents.
Pediatrics;
153(2)2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196395
13.
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Influenza Other Respir Viruses;
18(4): e13292, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654485
14.
Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022.
Vaccine;
41(26): 3923-3929, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211454
15.
Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses.
Int J Epidemiol;
52(6): 1716-1724, 2023 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37608733
16.
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022.
Int J Infect Dis;
130: 182-188, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893942
17.
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study.
BMJ;
382: e075286, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491022
18.
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
BMJ;
382: e074325, 2023 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487623
19.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Influenza Other Respir Viruses;
17(11): e13195, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019704
20.
Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
Trop Med Int Health;
17(5): 581-3, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22364582